Xi'an Taikomed Pharmaceutical Technology Co., Ltd.

Shaanxi University of Science and Technology

Minghui Chang

Yonghong Tang

Chengyuan Liang

Han Li

Huafeng Qi

Xingke Ju

Bin Tian

Lei Tian

Dan Yang

Juan Li

Yuzhi Liu

Wenbo Yao

Jingyi Li

Liang Xin

Xuechuan Wang

Guaiping Qiao

Yanjun Li

Peiyu Zhou

Zhuanmei Yuan

Kaiqi Shi

Qianqian Zhao

Yongbo Wang

Nan Hui

Liang Qi

Danni Tian

Juan Xia

Qiao Zeng

Ning Liu

Huayin Pu

Jian Cha

Juanna Song

Lili Wen

A compound having the following formula (I): is disclosed. The methods of preparing the compound of formula (I) are also disclosed.

Pleuromulin lauric acid ester with antibacterial activity and a method of preparing the same

A compound with antibacterial activity having the following formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Pleuromutilin ursodeoxycholic acid ester with antibacterial activity and a method of preparing the same

A compound with anti-drug resistant bacteria activity having the following formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Pleuromulin tretinoin ester with antibacterial activity and a method of preparing the same

A method of preparing a compound of formula (I): is disclosed. The compound of formula (I) can be used as an antioxidant agent. The compound can also be used as an antibacterial agent to inhibit18-596 and18-596.

Method of preparing a cinnamyl alcohol retinoic acid ester with antioxidant and antibacterial activities

A method of inhibiting leukotriene include: administrating a therapeutically effective amount of a compound of chemical formula I or II or a pharmaceutical acceptable salt thereof to a subject, Ris OH or OAc; X is C or N; and Ris H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO, or halogen, provided that when X is N, Ris nil.

Methods of using 1-O-acetylbritannilatone spiro aryl isoxazoline compounds

A method of inhibiting leukotriene, treating asthma, or treating inflammation includes: administrating to a subject a therapeutically effective amount of a compound of chemical formula I or II: or a pharmaceutical acceptable salt thereof. R, R, R, and Rare independently H, halogen, nitro, hydroxyl, cyano, benzyloxy, C-Cstraight or branched alkyl, C-Cstraight or branched haloalkyl, C-Cstraight or branched alkoxy.

Methods of inhibiting leukotriene, treating asthma and treating inflammation

A compound having the formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Hydroxytyrosol p-phenylenedicarboxylate having antioxidant activity and a method of preparing the same

A method of preparing 6-chloro-5-nitro-2,4-diaminopyrimidine includes: reacting guanidine hydrochloride with ethyl carbamoylacetate and sodium hypochlorite in the presence of a metal nitrate salt and acetate anhydride in an organic solvent. 

Method of preparing 6-chloro-5-nitro-2,4-diaminopyrimidine and its application thereof

A compound having the following formula I: In formula I, Rand Rare independently H, alkyl, alkoxy, and halogen. A method of preparing the compound of formula I is also disclosed.

13-hydroxysparteine cinnamic acid derivatives with anti-tumor activities and a method of preparing the same

Growing community of inventors

Xi'an, China

Minghui Chang